114 related articles for article (PubMed ID: 11836298)
1. Divergent effects of retinoic acids on the expression of ERalpha and 17beta-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells (RL 95-2).
Li XH; Li H; Xiao ZJ; Piao YS
J Clin Endocrinol Metab; 2002 Feb; 87(2):640-9. PubMed ID: 11836298
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acids increase 17 beta-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, and cyclic adenosine 3',5'-monophosphate only in JEG-3 cells.
Piao YS; Peltoketo H; Jouppila A; Vihko R
Endocrinology; 1997 Mar; 138(3):898-904. PubMed ID: 9048588
[TBL] [Abstract][Full Text] [Related]
3. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase.
Ito K; Suzuki T; Moriya T; Utsunomiya H; Sugawara A; Konno R; Sato S; Sasano H
J Clin Endocrinol Metab; 2001 Jun; 86(6):2721-7. PubMed ID: 11397877
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
5. Expression of retinoic acid receptors in human endometrial carcinoma.
Tanabe K; Utsunomiya H; Tamura M; Niikura H; Takano T; Yoshinaga K; Nagase S; Suzuki T; Ito K; Matsumoto M; Hayashi S; Yaegashi N
Cancer Sci; 2008 Feb; 99(2):267-71. PubMed ID: 18271925
[TBL] [Abstract][Full Text] [Related]
6. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
8. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression.
Miettinen MM; Mustonen MV; Poutanen MH; Isomaa VV; Vihko RK
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):839-45. PubMed ID: 8615778
[TBL] [Abstract][Full Text] [Related]
9. Expression of 17beta-hydroxysteroid dehydrogenase type 1 and type 2, P450 aromatase, and 20alpha-hydroxysteroid dehydrogenase enzymes in immature, mature, and pregnant rats.
Akinola LA; Poutanen M; Vihko R; Vihko P
Endocrinology; 1997 Jul; 138(7):2886-92. PubMed ID: 9202232
[TBL] [Abstract][Full Text] [Related]
10. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
Jansson A; Gunnarsson C; Stål O
Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
[TBL] [Abstract][Full Text] [Related]
11. Enzymes as modulators in malignant transformation.
Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acids promote the action of aromatase and 17beta-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17beta-estradiol in placental cells.
Zhu SJ; Li Y; Li H; Wang YL; Xiao ZJ; Vihko P; Piao YS
J Endocrinol; 2002 Jan; 172(1):31-43. PubMed ID: 11786372
[TBL] [Abstract][Full Text] [Related]
13. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
[TBL] [Abstract][Full Text] [Related]
14. Differential growth regulation by all-trans retinoic acid is determined by protein kinase C alpha in human pancreatic carcinoma cells.
Rosewicz S; Brembeck F; Kaiser A; Marschall ZV; Riecken EO
Endocrinology; 1996 Aug; 137(8):3340-7. PubMed ID: 8754760
[TBL] [Abstract][Full Text] [Related]
15. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
[TBL] [Abstract][Full Text] [Related]
16. Human 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle.
Mustonen MV; Isomaa VV; Vaskivuo T; Tapanainen J; Poutanen MH; Stenbäck F; Vihko RK; Vihko PT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1319-24. PubMed ID: 9543162
[TBL] [Abstract][Full Text] [Related]
17. Cloning of rat 17 beta-hydroxysteroid dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes.
Akinola LA; Poutanen M; Vihko R
Endocrinology; 1996 May; 137(5):1572-9. PubMed ID: 8612487
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.
Cheng YH; Yin P; Xue Q; Yilmaz B; Dawson MI; Bulun SE
J Clin Endocrinol Metab; 2008 May; 93(5):1915-23. PubMed ID: 18270252
[TBL] [Abstract][Full Text] [Related]
19. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.
Rizner TL; Smuc T; Rupreht R; Sinkovec J; Penning TM
Mol Cell Endocrinol; 2006 Mar; 248(1-2):126-35. PubMed ID: 16338060
[TBL] [Abstract][Full Text] [Related]
20. Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells.
Castagnetta LA; Carruba G; Traina A; Granata OM; Markus M; Pavone-Macaluso M; Blomquist CH; Adamski J
Endocrinology; 1997 Nov; 138(11):4876-82. PubMed ID: 9348218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
